Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19

ABSTRACT: Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19

PROVIDER: PRJNA680293 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13112200_1.fastq.gz	Fastqsanger.gz
	SRR13112200_2.fastq.gz	Fastqsanger.gz
	SRR13112300_1.fastq.gz	Fastqsanger.gz
	SRR13112300_2.fastq.gz	Fastqsanger.gz
	SRR13112400_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 4236

Similar Datasets

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.

Project description:COVID-19 exhibits extensive patient-to-patient heterogeneity. To link immune response variation to disease severity and outcome over time, we longitudinally assessed circulating proteins as well as 188 surface protein markers, transcriptome, and T cell receptor sequence simultaneously in single peripheral immune cells from COVID-19 patients. Conditional-independence network analysis revealed primary correlates of disease severity, including gene expression signatures of apoptosis in plasmacytoid dendritic cells and attenuated inflammation but increased fatty acid metabolism in CD56dimCD16hi NK cells linked positively to circulating interleukin (IL)-15. CD8+ T cell activation was apparent without signs of exhaustion. Although cellular inflammation was depressed in severe patients early after hospitalization, it became elevated by days 17-23 post symptom onset, suggestive of a late wave of inflammatory responses. Furthermore, circulating protein trajectories at this time were divergent between and predictive of recovery versus fatal outcomes. Our findings stress the importance of timing in the analysis, clinical monitoring, and therapeutic intervention of COVID-19.

| S-EPMC7874909 | biostudies-literature

Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19

Project description:COVID-19 exhibits extensive clinical heterogeneity ranging from asymptomatic infection to death. Unraveling the basis of immune response differences across individuals is critical for developing effective therapeutics and prophylactics. We longitudinally assessed 192 surface protein markers, the transcriptome, and T-cell receptor sequence profiles simultaneously in single peripheral immune cells from COVID-19 patients, and compared to age-matched healthy control samples.

2021-02-10 | GSE161918 | GEO

Differential Immune Transcriptomic Profiles between Vaccinated and Resolved HCV Reinfected Subjects

Project description:We applied a systems immunology approach to characterize longitudinal changes in the peripheral blood transcriptomic signatures in eight subjects who spontaneously resolved two HCV infections Furthermore, we compared these signatures with those induced by an HCV T cell-based vaccine regimen.

2022-10-25 | GSE206397 | GEO

Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis [Tissue_RNA-seq]

Project description:we present a novel path to drug repurposing to identify new immunotherapies for ASCVD. The integration of time of-flight mass cytometry (CyTOF) and RNA-sequencing identified unique inflammatory signatures in peripheral blood mononuclear cells (PBMCs) stimulated with ASCVD plasma. By comparing these inflammatory signatures to large-scale gene expression data from the LINCS L1000 dataset, we identified drugs that could reverse this inflammatory response. In conclusion, a systems immunology-driven drug repurposing with pre- clinical validation strategy can aid the development of new cardiovascular immunotherapies.

2023-04-23 | GSE230216 | GEO

Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis [DRUG_RNA-seq]

2023-04-23 | GSE230215 | GEO

Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis [RNA-seq_PBMC]

2023-04-23 | GSE230214 | GEO

NTM & Healthy Donor Immunology & Genomics

Project description:NTM & Healthy Donor Immunology & Genomics

| PRJNA853847 | ENA

NTM & Healthy Donor Immunology & Genomics

Project description:NTM & Healthy Donor Immunology & Genomics

| PRJNA853848 | ENA

Nanostring ncounter NHP Immunology V2 panel

Project description:The gene expression analysis of the RNA samples were analyzed with NanoString Non Human Primate immunology panel comprised of 754 immune related gene

2021-12-25 | GSE192584 | GEO

Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Project description:Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

| PRJNA957855 | ENA